Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PharmaDirections' novel acid and alkali stabilising packaging

This article was originally published in Scrip

Executive Summary

A patent has been filed by the US drug development management firm PharmaDirections on packaging that stabilises acidic- and alkaline-labile compounds. The process may be useful for products where it is not desirable to develop acid or alkaline stable formulations, the company says. PharmaDirections, which is based on North Carolina's Research Triangle Park, was founded in 2003 to speed the development of products for clients, and it assigns inventions royalty-free to clients when these are produced as part its work.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts